GR1000490B - Μεθοδος παρασκευης 4-φωσφορικων παραγωγων γλυκοζιτη επιποδοφυλλ οτοξινης. - Google Patents

Μεθοδος παρασκευης 4-φωσφορικων παραγωγων γλυκοζιτη επιποδοφυλλ οτοξινης.

Info

Publication number
GR1000490B
GR1000490B GR880100512A GR880100512A GR1000490B GR 1000490 B GR1000490 B GR 1000490B GR 880100512 A GR880100512 A GR 880100512A GR 880100512 A GR880100512 A GR 880100512A GR 1000490 B GR1000490 B GR 1000490B
Authority
GR
Greece
Prior art keywords
glucosite
epipodophyllotoxinc
preparation
ammonium derivatives
derivatives
Prior art date
Application number
GR880100512A
Other languages
English (en)
Other versions
GR880100512A (en
Inventor
F John Kadow
G Mark Saulnier
D Peter Senter
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of GR880100512A publication Critical patent/GR880100512A/el
Publication of GR1000490B publication Critical patent/GR1000490B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)

Abstract

Τα φωσφορικά παράγωγα γλυκοζιτών της 4-απομεθυλοεπιποδοφυλλοτοξίνης είναι νέοι παράγοντες κατά του όγκου και τα άλατα αυτών, προσφέρουν το φαρμακευτικό πλεονέκτημα της μεγάλης διαλυτότητας στο νερό. ω
GR880100512A 1987-08-04 1988-08-04 Μεθοδος παρασκευης 4-φωσφορικων παραγωγων γλυκοζιτη επιποδοφυλλ οτοξινης. GR1000490B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (2)

Publication Number Publication Date
GR880100512A GR880100512A (en) 1989-05-25
GR1000490B true GR1000490B (el) 1992-07-30

Family

ID=26765636

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100512A GR1000490B (el) 1987-08-04 1988-08-04 Μεθοδος παρασκευης 4-φωσφορικων παραγωγων γλυκοζιτη επιποδοφυλλ οτοξινης.

Country Status (34)

Country Link
US (3) US4904768A (el)
JP (1) JPH0699465B2 (el)
KR (1) KR900006230B1 (el)
CN (1) CN1027169C (el)
AT (1) AT398974B (el)
BE (1) BE1002982A4 (el)
CA (1) CA1310637C (el)
CH (1) CH676716A5 (el)
CY (1) CY1625A (el)
CZ (1) CZ286893B6 (el)
DD (2) DD299067A5 (el)
DE (1) DE3826562A1 (el)
DK (2) DK169344B1 (el)
ES (1) ES2010775A6 (el)
FI (1) FI87790C (el)
FR (1) FR2622193B1 (el)
GB (1) GB2207674B (el)
GR (1) GR1000490B (el)
HK (1) HK6392A (el)
HU (3) HU208147B (el)
IE (1) IE61040B1 (el)
IL (1) IL87290A (el)
IT (1) IT1226825B (el)
LU (2) LU87290A1 (el)
MX (1) MX173843B (el)
MY (1) MY104321A (el)
NL (2) NL192683C (el)
NO (4) NO170284C (el)
NZ (1) NZ225615A (el)
PT (1) PT88186B (el)
SE (1) SE502214C2 (el)
SG (1) SG101291G (el)
SK (1) SK279325B6 (el)
YU (3) YU143688A (el)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (el) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JPH07632B2 (ja) * 1991-12-23 1995-01-11 ブリストル−マイヤーズ スクイブ カンパニー エトポシド４’−ホスフェート二ナトリウム塩の安定な六水和物
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
WO1996040886A1 (en) * 1995-06-07 1996-12-19 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
WO1997036619A2 (en) * 1996-04-01 1997-10-09 Epix Medical, Inc. Bioactivated diagnostic imaging contrast agents
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
US20050009759A1 (en) * 2001-10-26 2005-01-13 Claude Monneret Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
KR20120068769A (ko) 2002-07-15 2012-06-27 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
CN1747747B (zh) * 2003-01-06 2012-09-05 安吉奥开米公司 作为穿过血脑屏障的载体的抑酶肽及类似物
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
CN101160403B (zh) * 2005-02-18 2014-08-13 安吉奥开米公司 转运化合物穿过血脑屏障的分子
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
WO2007009229A1 (en) 2005-07-15 2007-01-25 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8263644B2 (en) * 2007-09-13 2012-09-11 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
JP5809415B2 (ja) 2007-11-09 2015-11-10 ペレグリン ファーマシューティカルズ，インコーポレーテッド 抗ｖｅｇｆ抗体の組成物および方法
AR069798A1 (es) 2007-12-20 2010-02-17 Novartis Ag Derivados de 1, 3-tiazol, metodos para su preparacion, composiciones farmaceuticas que los comprenden y su uso en la manufactura de medicamentos para el tratamiento de enfermedades mediadas por la fosfatidilinositol 3-cinasa.
US8710013B2 (en) * 2008-04-18 2014-04-29 Angiochem Inc. Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
BRPI0920121A2 (pt) 2008-10-15 2019-09-24 Angiochem Inc conjugados de etoposida e doxorubicina para liberação de fármaco
MX2011005963A (es) * 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
CN102300987A (zh) 2008-12-17 2011-12-28 安吉奥开米公司 膜型-1基质金属蛋白抑制剂及其用途
EP2421562B1 (en) 2009-04-20 2019-03-13 Angiochem Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
CN102596993A (zh) 2009-07-02 2012-07-18 安吉奥开米公司 多聚体肽结合物以及其应用
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
CA2786294A1 (en) 2010-02-22 2011-08-25 F. Hoffmann-La Roche Ag Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
ES2611885T3 (es) 2011-01-31 2017-05-11 Novartis Ag Derivados heterocíclicos novedosos
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
PL2771342T3 (pl) 2011-10-28 2016-11-30 Nowe pochodne puryny i ich zastosowanie w leczeniu chorób
CA2855994A1 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
CA2872526A1 (en) 2012-05-16 2013-11-21 Novartis Ag Dosage regimen for a pi-3 kinase inhibitor
WO2014098877A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
EP3076969B1 (en) 2013-12-06 2021-09-01 Novartis AG Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor
US10980892B2 (en) 2015-06-15 2021-04-20 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
US20180280370A1 (en) 2015-11-02 2018-10-04 Novartis Ag Dosage regimen for a phosphatidylinositol 3-kinase inhibitor
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (el) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH481094A (de) * 1966-12-13 1969-11-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd ４′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
NO172440C (no) 1993-07-21
NO170284B (no) 1992-06-22
GR880100512A (en) 1989-05-25
IE61040B1 (en) 1994-09-07
FR2622193A1 (fr) 1989-04-28
NL8801934A (nl) 1989-03-01
NL192683C (nl) 1997-12-02
SE8802815D0 (sv) 1988-08-03
YU10490A (en) 1990-06-30
YU10390A (en) 1990-06-30
DK11992D0 (da) 1992-01-31
PT88186A (pt) 1989-06-30
USRE35524E (en) 1997-06-03
GB2207674B (en) 1991-09-11
CH676716A5 (el) 1991-02-28
SE8802815L (sv) 1989-02-05
KR890003790A (ko) 1989-04-18
HU905862D0 (en) 1991-03-28
NL970042I2 (el) 2005-06-01
DE3826562C2 (el) 1993-04-08
CN1027169C (zh) 1994-12-28
AT398974B (de) 1995-02-27
CN1061225A (zh) 1992-05-20
MX9202851A (es) 1992-06-30
MY104321A (en) 1994-03-31
HK6392A (en) 1992-01-17
NO883299D0 (no) 1988-07-26
GB2207674A (en) 1989-02-08
YU143688A (en) 1990-04-30
FI883596A (fi) 1989-02-05
DD299067A5 (de) 1992-03-26
IT1226825B (it) 1991-02-19
ATA195588A (de) 1994-07-15
SK541288A3 (en) 1998-10-07
AU610619B2 (en) 1991-05-23
NO920665D0 (no) 1992-02-20
NL970042I1 (nl) 1998-03-02
BE1002982A4 (fr) 1991-10-15
GB8818462D0 (en) 1988-09-07
HU208147B (en) 1993-08-30
IE882378L (en) 1989-02-04
SE502214C2 (sv) 1995-09-18
NO920277D0 (no) 1992-01-22
DK434088D0 (da) 1988-08-03
DK169344B1 (da) 1994-10-10
AU2030688A (en) 1989-06-08
FI883596A0 (fi) 1988-08-01
IL87290A0 (en) 1989-01-31
NO920277L (no) 1989-02-24
PT88186B (pt) 1995-07-03
ES2010775A6 (es) 1989-12-01
NL192683B (el) 1997-08-01
LU90138I2 (fr) 1997-11-26
HU211960A9 (en) 1996-01-29
IL87290A (en) 1993-01-31
CA1310637C (en) 1992-11-24
NZ225615A (en) 1991-06-25
CZ541288A3 (cs) 1999-12-15
SK279325B6 (sk) 1998-10-07
IT8821535A0 (it) 1988-07-28
FI87790C (fi) 1993-02-25
NO920665L (no) 1989-02-24
FR2622193B1 (fr) 1993-12-17
JPH01100188A (ja) 1989-04-18
DD274423A5 (de) 1989-12-20
SG101291G (en) 1992-01-17
JPH0699465B2 (ja) 1994-12-07
CY1625A (en) 1992-07-10
FI87790B (fi) 1992-11-13
US5041424A (en) 1991-08-20
DK11992A (da) 1992-01-31
NO170284C (no) 1992-09-30
NO883299L (no) 1989-02-24
HUT47303A (en) 1989-02-28
KR900006230B1 (ko) 1990-08-27
US4904768A (en) 1990-02-27
LU87290A1 (fr) 1990-02-07
DK434088A (da) 1989-02-05
DE3826562A1 (de) 1989-02-16
HU202547B (en) 1991-03-28
MX173843B (es) 1994-03-30
CZ286893B6 (cs) 2000-07-12
NO1998002I1 (no) 1998-01-14
NO172440B (no) 1993-04-13

Similar Documents

Publication Publication Date Title
GR1000490B (el) Μεθοδος παρασκευης 4-φωσφορικων παραγωγων γλυκοζιτη επιποδοφυλλ οτοξινης.
IT8619361A0 (it) Androstendione derivati 4-sostituiti e procedimento per laloro preparazione.
DE3785198D1 (de) Liposomes praeparat und antibiotikum.
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
ES2017956B3 (es) Procedimiento para preparar derivados de 4-acetoxi-3-hidroxietilazetidin-2-ona.
FI882945A (fi) Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO863608D0 (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
GR1000467B (el) Μεθοδος παρασκευης τρικυκλικων παραγωγων 3-οξο-προπανονιτριλιου.
FI912315A0 (fi) Menetelmä furo/3,4-c/pyridiinijohdosten valmistamiseksi ei-raseemisessa muodossa
IT8522327A0 (it) Derivati macromolecolarizzati di cdp-colina, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
NO865181L (no) Fremgangsmaate for fremstilling av gamma-thiobutyrolacton-derivater.
DK449986A (da) 12- og 13-substituerede ergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
NO904805L (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
IT8620756A0 (it) Procedimento per la preparazione di derivati n-allil-piperidinici.
IT8067851A0 (it) Derivati di cefalosporina sommini strabili per via orale e procedimento per la loro preparazione
NO880992D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
IT1207805B (it) Procedimento per preparare coniugati di metalloproteine e nuovi derivati dei coniugati stessi.
MX12051A (es) Procedimiento para preparar nuevos derivados de la1-bencenosulfonil-2-oxo-5-alquiltio-pirrolidina.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO174150C (no) Fremgangsmåte for fremstilling av furo-(3,4-c)pyridin-derivater i ikke-racemisk form
FI844450A0 (fi) Foerfarande foer framstaellning av 2-(2-tienyl)-imidazo/4,5-b/pyridin-derivat och farmaceutiskt acceptabla syraadditionssalter daerav.

Legal Events

Date Code Title Description
MA Right expired